Table 1 Sample demographics.

From: Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA

Study

 

Age

BMI

Female%

 

N

Mean

s.d.

Mean

s.d.

 

EGCUT

3,287

46.3

19.5

26.4

5.4

58

ERF

2,118

48.2

14.7

26.7

4.7

58

FTC

664

23.9

2.1

23.1

3.7

50

FR97

3,661

45.3

12.8

26.3

4.5

55

COROGENE

828

53.2

13.2

26.6

4.1

54

GenMets

572

55.8

7.3

27.2

4.5

57

HBCS

708

61.3

2.9

27.1

4.1

60

KORA

1,745

60.9

8.8

28.2

4.8

52

LLS

2,227

59.2

6.8

25.4

3.5

54

NTR

1,192

38.8

12.8

24.6

4.2

64

NFBC 1966

4,709

31.2

0.4

24.6

4.1

51

PredictCVD

374

47.5

14.6

26.6

4.4

37

PROTE

597

38.3

16

25.2

4.6

51

YFS

2,390

37.7

5.0

26

4.7

54

  1. BMI, body mass index; COROGENE, Genetic Predisposition of Coronary Heart Disease in Patients Verified with Coronary Angiogram; EGCUT, Estonian Genome Center of University of Tartu Cohort; ERF, Erasmus Rucphen Family Study; FR97, a subsample of FINRISK 1997; FTC, Finnish Twin Cohort; GenMets, Genetics of METabolic Syndrome; HBCS, Helsinki Birth Cohort Study; KORA, Cooperative Health Research in the Region of Augsburg; LLS, Leiden Longevity Study; N, number of individuals with both genotype and metabolite traits analysed; NFBC 1966, Northern Finland Birth Cohort 1966; NTR, Netherlands Twin Register; PredictCVD, FINRISK subsample of incident cardiovascular cases and controls; PROTE, EGCUT sub-cohort; YFS, The Cardiovascular Risk in Young Finns Study.
Back to article page